With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
Specialized brain training targeted at the regions of a rat’s brain that process sound reversed many aspects of normal, age-related cognitive decline and improved the health of the brain cells, according to a new study from researchers at UCSF.
More funding will be available this year to support UCSF students from socio- or economically disadvantaged backgrounds, as a result of a 300 percent increase in federal funding for Scholarships for Disadvantaged Students (SDS) program for the upcoming school year.
Results of a clinical trial through the UCSF-sponsored Immune Tolerance Network may offer the first new treatment in 40 years for the devastating blood vessel disease known as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
UCSF Medical Center ranks among the nation’s top 10 premier hospitals for the tenth consecutive year and is the best in Northern California, according to the new 2010-2011 America’s Best Hospitals survey conducted by U.S. News & World Report.
A diabetes-care program designed by clinical pharmacy faculty in the UCSF School of Pharmacy Center for Self-Care has just launched in Northern California as a service for members of the California Public Employees Retirement System (CalPERS) with Blue Shield health coverage.